v3.26.3
CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2026
Oct. 31, 2025
Current Assets    
Cash $ 2,265,000 $ 221,000
Accounts receivable, net of allowance for bad debts 245,000 35,000
Prepaid expenses 179,000 279,000
Inventories 796,000 423,000
Total Current Assets 3,485,000 958,000
Property and equipment, net 595,000 569,000
Security deposits 18,000
TOTAL ASSETS 4,098,000 1,527,000
Current Liabilities    
Accounts payable and accrued expenses 2,075,000 1,980,000
Finance lease obligations 30,000 33,000
Convertible promissory note, net of debt discount of $2,000 and $7,000 248,000 243,000
Obligation to repurchase shares 22,000 19,000
Deferred revenue 818,000 598,000
Share-based compensation liability to related parties 227,000
Total Current Liabilities 3,420,000 2,873,000
Long term finance lease obligations 59,000 77,000
Total Liabilities 3,479,000 2,950,000
Stockholders’ Equity (Deficit)    
Common stock, $0.001 par value, 2,500,000,000 shares authorized; 7,837,441 and 6,747,441 shares issued and outstanding, respectively 8,000 7,000
Additional paid-in capital 73,383,000 66,304,000
Accumulated deficit (72,808,000) (67,734,000)
Total equity (deficit) attributable to Zeo ScientifiX, Inc. 583,000 (1,423,000)
Non-controlling interests 36,000
Total Stockholders’ Equity (Deficit) 619,000 (1,423,000)
TOTAL LIABILITIES, SHARES SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ EQUITY (DEFICIT) 4,098,000 1,527,000
Series C Preferred Stock [Member]    
Shares Subject To Possible Redemption    
Preferred stock value